Jeff Aronin is one of the foremost executives in the world of biomedical sciences. Today, he’s the Chairman and CEO of Paragon Biosciences. His career really took off back in 2000, when he founded Ovation Pharmaceuticals. With his background and entrepreneurial spirit, he’s been a leader in solving problems for patients for almost twenty years.
For Aronin, unsolved problems have a lot of allure. He’s the type of guy to seek out new challenges. This is particularly true because he knows that medical concerns have so much impact in people’s lives. He takes special pride in developing solutions that save patients time, money and complications. For example, with medications developed by Aronin’s firm, sick children can now avoid surgeries.
Intervention by medication instead of surgery eliminates risks from anesthesia and infection. Medication is also typically far less expensive than surgical intervention. There’s no down time for recovery. Dosages can be adjusted as needed. Breakthroughs like this can change the whole prognosis for people with difficult-to-treat conditions.
Aronin is not just an expert at managing the scientific side of Paragon. He’s also well-versed in regulatory practices in the US. Shepherding a drug through the FDA approval process is a very important skillset. It’s one that Aronin has mastered. He knows how to dot all the i’s and cross all the t’s to eliminate hiccups in the approval process.
Apart from his work with Paragon, Aronin is proud to be a part of the MATTER initiative. This is a healthcare industry incubator in Chicago. Aronin is always looking to the future, and he’s very excited by some of the innovative ideas he’s seeing.
Jeff Aronin was educated at Northern Illinois University and DePaul University. In addition to his work, Aronin is a proud philanthropist. He and his wife devote lots of time and money to charity. Their Aronin Family Foundation gives money to hospitals and clinics all over the world.